Stock screener

PLUR

Conviction 0HealthcareScan · Mon, Aug 10, 2026
PLUR$1.76-3.30%
ResistanceSupportVol 14
63 bars
Vol MA14 18.36K
May 11May 28Jun 16Jul 6Jul 23Aug 10
Pluri Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.pluri-biotech.com
Price1.76
Change-3.30%
Gap-2.75%
Rel volume0.18×
Avg volume27.09K
Avg $ vol47.11K
SMA 201.73
SMA 501.98
SMA 2002.99
Price vs 50-11.30%
Price vs 200-41.19%
MA stackbearish
50/200 cross
Supertrenddown · 1.99
RSI (14)47
MACD hist0.04
MACD crossbull · 3d
Stoch %K / %D62 / 68
ADX (14)16
+DI / −DI22 / 26
RSI divergenceBullish
MACD divergenceBullish
ATR %+7.90%
ADR %7.45%
52w high5.68
52w low0.0000
From 52w high-69.01%
Above 52w low
New 52w highNo
SqueezeOff
Bollinger width26.65%
%B0.57
Donchian pos55.43%
Donchian high2.01
Donchian low1.45
AVWAP (52w high)3.21
vs AVWAP high-45.16%
AVWAP (52w low)2.29
vs AVWAP low-23.28%
OBV trendUp
Chaikin MF (20)-0.15
Today vs 20d0.18×
Avg vol (14d)18.36K
Avg vol (20d)27.09K
Avg $ vol (20d)47.11K
Market cap18.99M
RS 3m (vs SPY)-51.21%
RS 6m (vs SPY)-64.25%
RS line new highNo
Trend template0/8
Technical rank22.0
1 week+11.75%
1 month+2.62%
3 months-49.50%
6 months-49.28%
1 year-63.56%
YTD-41.14%
P/E-0.84
P/B-1.02
P/S14.21
P/FCF-0.96
EPS-3.56
Div yield
ROE121.39%
ROA-86.67%
Debt/Eq-0.00
Current0.33
EV/EBITDA-0.71
Gross margin48.95%
Net margin
Rev growth309.82%
EPS growth-8.11%
Price target
Target upside
Analyst rating
Institutional
Ent. value15.58M
Revenue167K
Net income-5.55M
Gross profit56K
Free cash flow-19.83M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out10.79M
Employees142
ListedWed, Oct 9, 1991
Free float6.96M
Float %69.2%
Short interest23.99K
Days to cover0.4d
Short volume55.0%
Squeeze score12 / 100
Next earnings
EPS forecast
Last EPS vs est
Last surprise
Setup gradeD
Conviction0 / 100
Pattern quality
Tech rank22.0 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction
Pattern family
Resistance2.41
Support1.51
Days since event
Candle confirm
News sentiment

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in PLUR

All disclosures →
No recent disclosed trades by Congress in PLUR. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in PLUR · 7 buys

InsiderSideShares
Manieu Alexandre Weinstein
Director · Warrants · 2026-04-21
Grant312.5K
Chutzpah Holdings Ltd
10% owner · Common Stock · 2026-04-21
Grant312.5K
Chutzpah Holdings Ltd
10% owner · Warrants · 2026-04-21
Grant312.5K
Manieu Alexandre Weinstein
Director · Common Stock · 2026-04-21
Grant312.5K
Chutzpah Holdings Ltd
10% owner · Common Stock · 2026-03-31
Other
Manieu Alexandre Weinstein
Director · Warrants · 2026-03-31
Other
Manieu Alexandre Weinstein
Director · Warrants · 2026-03-31
Grant312.5K
Chutzpah Holdings Ltd
10% owner · Warrants · 2026-03-31
Other
Chutzpah Holdings Ltd
10% owner · Common Stock · 2026-03-31
Grant312.5K
Chutzpah Holdings Ltd
10% owner · Warrants · 2026-03-31
Grant312.5K

SEC filings

EDGAR filings in PLUR · 5 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.